We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
Ask ADVFN Intelligence (AI)
WILMINGTON, Del., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced...
- Encouraging signs of anti-tumor activity including objective responses observed in patients with SMARCA4-mutated non-small cell lung cancer (NSCLC) and esophageal cancer in early PRT3789...
PRT3789, a novel, highly-selective SMARCA2 degrader in patients with advanced solid tumors with a SMARCA4 mutation oral session presentation: September 13, 2024, 4:00 PM CEST (10:00 AM EST...
Interim Phase 1 data for its first-in-class, highly selective IV SMARCA2 degrader, PRT3789, selected for an oral presentation at the European Society for Medical Oncology (ESMO) Congress 2024 in...
Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor activity of either agent because of the complementary nature of the...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.03 | 1.52284263959 | 1.97 | 2.08 | 1.82 | 174310 | 1.94843971 | CS |
| 4 | -0.61 | -23.3716475096 | 2.61 | 2.72 | 1.82 | 275297 | 2.24970248 | CS |
| 12 | -2.93 | -59.4320486815 | 4.93 | 6.8 | 1.82 | 279202 | 3.74740966 | CS |
| 26 | -3.75 | -65.2173913043 | 5.75 | 6.8 | 1.82 | 171578 | 3.93954712 | CS |
| 52 | -0.42 | -17.3553719008 | 2.42 | 6.8 | 1.66 | 156717 | 3.60968835 | CS |
| 156 | -14.43 | -87.8271454656 | 16.43 | 20.1099 | 1.66 | 166313 | 7.10156043 | CS |
| 260 | -23.76 | -92.2360248447 | 25.76 | 95.375 | 1.66 | 191034 | 18.92180382 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
